Ensuring psychedelic treatments and research do not leave anyone behind.

Melissa A Simon

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2023;49(1):294-295

PMID: 37604977

Free Full Text on Nature Publishing Group View on PubMed

Abstract

Psychedelics are a promising approach to caring for persons living with severe mental illness. However, as with all clinical treatments and research in the US, health equity concerns must be considered and addressed. Ensuring health equity and health justice in psychedelic care delivery and research will require strategies to not only reduce disparities and preempt future disparities among minoritized and marginalized populations.

Address: Departments of Obstetrics and Gynecology, Preventive Medicine and Medical Social Sciences and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA. [email protected].

DOI: 10.1038/s41386-023-01710-4

Link outs

Free resources

Full Text Sources:

MeSH Terms: Hallucinogens, Lysergic Acid Diethylamide, Psilocybin